ACC/AHA冠脉病变分型评估PCI患者长期预后
C型病变组48个月PoCE发生率显著高于A/B1和B2组,且C型病变是PoCE和TLF的独立危险因素,提示其长期预后较差。
要点
- C型病变患者48个月PoCE发生率24.43%,高于A/B1型14.13%和B2型15.97%。
- C型病变是48个月PoCE(HR=1.59)和TLF(HR=2.31)的独立危险因素。
- 与A/B1和B2相比,C型病变PoCE风险分别增加91%和64%,TLF风险分别增加145%和155%。
核心结论
- ACC/AHA冠状动脉病变分型对PCI术后冠心病患者长期结局有良好区分度,C型病变与更差预后相关,临床管理中应足够重视。
研究设计与样本
- 按ACC/AHA分型分为A/B1型组(184例)、B2型组(457例)和C型组(614例),比较48个月终点事件。
主要发现
- 48个月PoCE发生率:C型组24.43%(150/614),A/B1型组14.13%(26/184),B2型组15.97%(73/457),C型组均显著更高(P<0.05)。
- 多因素Cox分析显示C型病变是48个月PoCE(HR=1.59,95%CI 1.21~2.08,P<0.001)和TLF(HR=2.31,95%CI 1.53~3.49,P<0.001)的独立危险因素。
- C型 vs A/B1的PoCE HR=1.91(95%CI 1.25~2.92,P=0.003),C型 vs B2的PoCE HR=1.64(95%CI 1.23~2.20,P<0.001)。
- C型 vs A/B1的TLF HR=2.45(95%CI 1.29~4.64,P=0.006),C型 vs B2的TLF HR=2.55(95%CI 1.62~4.02,P=0.001)。
临床怎么用
- 对PCI术后患者可依据ACC/AHA病变分型识别C型病变等高危人群,加强长期随访与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To evaluate the long-term prognosis of coronary artery disease (CAD) patients undergoing percutaneous coronary intervention (PCI) by risk stratification with American College of Cardiology (ACC)/American Heart Association (AHA) classification of coronary lesions. Methods: Data used in this study derived from the I-LOVE-IT 2 trial. I-LOVE-IT 2 trial was a prospective, multicenter, randomized, assessor-blinded, noninferiority study. A total of 1 255 patients in I-LOVE-IT 2 trial with only one lesion and underwent biodegradable polymer drug-eluting stent implantation were included and grouped according to ACC/AHA classification of coronary lesions, namely type A/B1 lesion group (n=184), type B2 lesion group (n=457) and type C lesion group (n=614). The primary endpoint was 48-month patient-oriented composite endpoint (PoCE), a composite of all-cause mortality, all myocardial infarction, stroke, and/or any revascularization. The secondary endpoints were target lesion failure (TLF), components of PoCE, major bleeding (bleeding academic research consortium(BARC) type 3-5) and definite/probable stent thrombosis within 48 months. The incidences of endpoint events were compared in the three groups. The multivariable Cox hazard ratio model was used to analyze the independent predictors of PoCE and TLF at 48 months. Results: Incidences of PoCE at 48 months were significantly higher in patients with type C lesion compared with patients with type A/B1 (24.43%(150/614) vs. 14.13%(26/184), P<0.05) or B2 lesion (24.43%(150/614) vs. 15.97%(73/457), P<0.05). The multivariable Cox hazard ratio model showed that the type C lesion were the independent predictors of 48-month PoCE (HR=1.59, 95%CI 1.21-2.08, P<0.001) and TLF (HR=2.31, 95%CI 1.53-3.49, P<0.001). After multivariable adjustment, the HRs of PoCE for patients with type C lesion versus type A/B1 and type B2 were 1.91 (95%CI 1.25-2.92, P=0.003) and 1.64 (95%CI 1.23-2.20, P<0.001), respectively. Meanwhile, the HRs of TLF for patients with type C lesion versus type A/B1 and type B2 were 2.45 (95%CI 1.29-4.64, P=0.006) and 2.55 (95%CI 1.62-4.02, P=0.001), respectively. Conclusions: The ACC/AHA classification of coronary lesions has good discrimination with long-term outcomes for CAD patients undergoing PCI. The type C lesion is associated with a worse prognosis, enough attention should be paid in these patients during routine clinical management. 目的: 探究我国当前医疗环境下,基于美国心脏病学会(ACC)和美国心脏协会(AHA)冠状动脉病变分型,比较不同的病变分型对行经皮冠状动脉介入治疗(PCI)的冠心病患者的长期临床预后的影响。 方法: 研究对象来自I-LOVE-IT 2,该研究是一项前瞻性、多中心、随机对照、对评价者设盲的非劣效性研究。本研究选取I-LOVE-IT 2研究中置入生物可降解涂层药物洗脱支架且仅有一处冠状动脉病变的患者1 255例,根据ACC/AHA冠状动脉病变分型定义,分为A/B1型病变组(184例)、B2型病变组(457例)以及C型病变组(614例)。本研究的主要终点为48个月患者源性复合终点(PoCE),即包含全因死亡、心肌梗死、缺血性卒中和/或血运重建的复合终点;次要终点为48个月的靶病变失败(TLF)、PoCE的各组成成分、出血学术研究联合会(BARC)定义的主要出血(BARC 3~5型)以及肯定或极可能的支架内血栓。比较3组的终点事件发生情况,采用多因素Cox比例风险模型分析48个月PoCE和TLF的独立危险因素,并比较不同病变分型患者的PoCE和TLF事件的发生风险。 结果: C型病变组患者的48个月PoCE发生率高于A/B1型病变组[24.43%(150/614)比14.13%(26/184),P<0.05]和B2型病变组[24.43%(150/614)比15.97%(73/457),P<0.05]。多因素Cox比例风险模型分析结果显示,C型病变是48个月PoCE(HR=1.59,95%CI 1.21~2.08,P<0.001)和TLF(HR=2.31,95%CI 1.53~3.49,P<0.001)的独立危险因素;与A/B1型病变组和B2型病变组相比,C型病变组PoCE的发生风险分别增加了91%(HR=1.91,95%CI 1.25~2.92,P=0.003)和64%(HR=1.64,95%CI 1.23~2.20,P<0.001)。与A/B1型病变组和B2型病变组相比,C型病变组TLF的发生风险分别增加了145%(HR=2.45,95%CI 1.29~4.64,P=0.006)和155%(HR=2.55,95%CI 1.62~4.02,P=0.001)。 结论: ACC/AHA冠状动脉病变分型能够较好评估PCI术后冠心病患者的心血管不良事件发生风险,合并C型病变者的长期临床预后较差,在临床实践中应给予足够的重视。.
引用
- Qiu MH, Zhao WC, Fan P, et al. [Evaluating the long-term prognosis of coronary artery disease patients undergoing percutaneous coronary intervention by risk stratification with ACC/AHA classification of coronary lesions]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020. PMID: 32135610. doi:10.3760/cma.j.issn.0253-3758.2020.02.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。